Syqe is an innovative med-tech company founded in 2011 with the mission to relieve the pain and suffering of as many people as possible in the fastest possible way. We disrupted the pharmaceutical industry with groundbreaking technologies that allow for metered and consistent dosing of molecules by inhalation. Our inhalation platform is designed to deliver a wide array of substances, starting with medical cannabis, while complying with standardization principles of the healthcare industry. The SyqeAir Inhaler is a regulatory-approved medical device (certifications including EU-GMP, CE, MDL, MDEL, ARTG, and AMAR) preloaded with a controlled substance clinically proven to provide effective and safe treatment. Paving the way from a revolutionary vision to a promising reality is a meaningful journey. We collect meaningful experiences as we move forward and overcome challenges by nurturing our unique culture that makes us who we are. Syqe is based in Tel Aviv and employs over 120 employees.